Fundraising Fox

Rachel Tsunemoto Hislop, PhD

Investor

Principal, Director of Research at Two Bear Capital

San Diego, California, United States

Writes $3M – $10M checks

About

Rachel Tsunemoto Hislop pairs UC San Diego stem-cell and developmental neurobiology research and Acorda medical affairs experience with leading San Diego research team that produces formal, data-driven insights across research-to-commercialization

Invests in

AI & Machine LearningBiotechCybersecurityEnterprise SoftwareHealthtech

Experience

  1. Two Bear CapitalPrincipal, Director of Researchcurrent2024 β€” present
  2. Two Bear CapitalPrincipal2020 β€” 2024
  3. Abilita Therapeutics, Inc.Board Observer2022 β€” 2024San Diego, California, United States
  4. Novoron BioscienceBoard Observer2021 β€” 2024San Diego, California, United States
  5. Acorda Therapeutics, Inc.Medical Science Liaison2017 β€” 2020
  6. UC San Diego HealthStem Cell and Molecular Biology Researcher2016 β€” 2017Greater San Diego Area
  7. FreelanceScience Communicator2013 β€” 2016Greater San Diego Area
  8. UC San DiegoNeuroscience Ph.D. Candidate and Research Associate2010 β€” 2016Greater San Diego Area
  9. MITUndergraduate Research Assistant2008 β€” 2009Greater Boston Area
  10. Merck (Neuroscience Drug Discovery Department)Summer Research Intern2007Greater Boston Area

Education

  1. Massachusetts Institute of TechnologyBachelor of Science (B.S.), Brain and Cognitive Studies
  2. UC San DiegoDoctor of Philosophy (Ph.D.), Neuroscience

Same school

Shared employers

Colleagues at Two Bear Capital